newsfilter
← Latest News
Business Wire·

Axcella, Now Axcella Therapeutics, to Host Virtual R&D Day on October 26, 2021

Event to feature an unveiling of Axcella's next clinical program, ongoing OHE and NASH programs, and platform Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogen